Why did TITANBIO.BO stock drop 80.00% intraday?

No confirmed filing explained the move at 10:57 AM IST. The drop likely reflects heavy selling, thin block liquidity, and stop-loss cascades. Check official filings on the company website and BSE for formal reasons.

What are the key technical levels for TITANBIO.BO stock today?

Intraday support sits near **INR 246.00**, the day low. Short-term resistance is the Bollinger middle at **INR 892.18** and the 50-day average at **INR 1,045.63**.

How does Meyka AI view TITANBIO.BO stock after the drop?

Meyka AI rates TITANBIO.BO **69.26/100** (Grade B, HOLD). The platform flags oversold conditions but notes valuation and liquidity risks. This is informational, not investment advice.

Are Meyka AI forecasts guarantees for TITANBIO.BO stock?

No. Meyka AI's forecasts are model-based projections. The monthly projection is **INR 1,088.06** and yearly **INR 1,002.87**, but they are not guarantees.

IN Stocks

TITANBIO.BO (Titan Biotech) down 80.00% intraday on BSE: heavy volume, oversold signal

ByDanny Kontos February 23, 2026

TITANBIO.BO stock tumbled 80.00% to INR 260.34 intraday on 23 Feb 2026 on the BSE, driven by heavy selling and a volume spike of 689,025 shares. We track this move as a top loser in the India healthcare space during the intraday session. The drop came from a previous close of INR 1,301.70, producing a one-day change of -1041.36 INR. No confirmed corporate filing explained the move at 10:57 AM IST, so traders are watching liquidity, technical oversold signals, and valuation gaps carefully.